TipRanks
Beyond Medical Technologies Inc (DE:7FM0)
FRANKFURT:7FM0
Germany Market
7FM0
Beyond Medical Technologies Inc
RESEARCH TOOLSreports

Beyond Medical Technologies Inc (7FM0) Ratios

0 Followers

Beyond Medical Technologies Inc Ratios

DE:7FM0's free cash flow for Q4 2025 was C$1.00. For the 2025 fiscal year, DE:7FM0's free cash flow was decreased by C$ and operating cash flow was C$-62.01. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 ― 0.77 0.02 0.22 1.67
Quick Ratio
 ― 0.77 0.02 0.22 1.67
Cash Ratio
 ― 0.38 0.02 0.15 1.55
Solvency Ratio
 ― -0.17 0.65 -0.19 -3.95
Operating Cash Flow Ratio
 ― -0.24 -0.17 -1.22 -2.58
Short-Term Operating Cash Flow Coverage
 ― -0.51 -1.83 -17.57 0.00
Net Current Asset Value
C$ ―C$ -10.18MC$ -620.66KC$ -334.72KC$ 232.38K
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.75 4.35 0.31 0.00
Debt-to-Equity Ratio
 ― 88.81 -0.10 -0.09 0.00
Debt-to-Capital Ratio
 ― 0.99 -0.11 -0.10 0.00
Long-Term Debt-to-Capital Ratio
 ― 0.98 0.00 0.00 0.00
Financial Leverage Ratio
 ― 118.71 -0.02 -0.29 2.33
Debt Service Coverage Ratio
 ― -0.53 -6.10 -1.27 0.00
Interest Coverage Ratio
 ― -3.36 0.00 0.00 0.00
Debt to Market Cap
 ― 1.93 0.22 0.07 0.00
Interest Debt Per Share
 ― 0.45 <0.01 <0.01 0.00
Net Debt to EBITDA
 ― -4.35 -0.13 0.90 0.69
Profitability Margins
Gross Profit Margin
―100.00%0.00%0.00%0.00%
EBIT Margin
―-18202.16%0.00%0.00%0.00%
EBITDA Margin
―-18202.16%0.00%0.00%0.00%
Operating Profit Margin
―-17314.34%0.00%0.00%0.00%
Pretax Profit Margin
―-23355.03%0.00%0.00%0.00%
Net Profit Margin
―-23355.03%0.00%0.00%0.00%
Continuous Operations Profit Margin
―-23355.03%0.00%0.00%0.00%
Net Income Per EBT
―100.00%0.08%107.97%167.31%
EBT Per EBIT
―134.89%83.35%100.64%104.47%
Return on Assets (ROA)
―-16.92%-2.06%-623.19%-229.70%
Return on Equity (ROE)
―-2008.64%0.05%178.06%-534.74%
Return on Capital Employed (ROCE)
―-22.93%70.73%163.86%-305.95%
Return on Invested Capital (ROIC)
―-16.58%78.30%180.00%-305.95%
Return on Tangible Assets
―-48.43%-2.06%-623.19%-229.70%
Earnings Yield
―-43.70%-0.10%-139.51%-117.68%
Efficiency Ratios
Receivables Turnover
 ― 0.01 0.00 0.00 0.00
Payables Turnover
 ― 0.00 0.00 0.00 0.00
Inventory Turnover
 ― 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 ― 0.00 0.00 0.00 0.00
Asset Turnover
 ― <0.01 0.00 0.00 0.00
Working Capital Turnover Ratio
 ― -0.01 0.00 0.00 0.00
Cash Conversion Cycle
 ― 30.14K 0.00 0.00 0.00
Days of Sales Outstanding
 ― 30.14K 0.00 0.00 0.00
Days of Inventory Outstanding
 ― 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 ― 0.00 0.00 0.00 0.00
Operating Cycle
 ― 30.14K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -0.06 -0.01 -0.06 -0.11
Free Cash Flow Per Share
 ― -0.06 -0.01 -0.06 -0.11
CapEx Per Share
 ― 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 ― 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 ― 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 ― 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 ― -0.14 -1.83 -17.57 0.00
Operating Cash Flow to Sales Ratio
 ― -148.29 0.00 0.00 0.00
Free Cash Flow Yield
―-27.75%-39.63%-123.37%-75.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -2.20 -971.89 -0.72 -0.85
Price-to-Sales (P/S) Ratio
 ― 534.40 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 ― 45.96 -0.45 -1.28 4.54
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -3.60 -2.52 -0.81 -1.33
Price-to-Operating Cash Flow Ratio
 ― -3.60 -2.52 -0.81 -1.33
Price-to-Earnings Growth (PEG) Ratio
 ― -0.01 20.13 0.01 0.02
Price-to-Fair Value
 ― 45.96 -0.45 -1.28 4.54
Enterprise Value Multiple
 ― -7.29 -0.88 -10.35 -0.84
Enterprise Value
 ― 15.24M 323.77K 393.06K 650.35K
EV to EBITDA
 ― -7.29 -0.88 -10.35 -0.84
EV to Sales
 ― 1.33K 0.00 0.00 0.00
EV to Free Cash Flow
 ― -8.95 -2.95 -0.75 -0.73
EV to Operating Cash Flow
 ― -8.95 -2.95 -0.75 -0.73
Tangible Book Value Per Share
 ― -0.36 -0.08 -0.04 0.03
Shareholders’ Equity Per Share
 ― <0.01 -0.08 -0.04 0.03
Tax and Other Ratios
Effective Tax Rate
 ― 0.00 0.00 0.00 0.00
Revenue Per Share
 ― <0.01 0.00 0.00 0.00
Net Income Per Share
 ― -0.10 >-0.01 -0.07 -0.18
Tax Burden
 ― 1.00 <0.01 1.08 1.67
Interest Burden
 ― 1.28 0.89 1.00 1.05
Research & Development to Revenue
 ― 25.84 0.00 0.00 0.00
SG&A to Revenue
 ― 85.25 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 ― 1.75 0.00 0.00 0.00
Income Quality
 ― 0.69 0.30 0.95 0.64
Currency in CAD